Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.

Dey AK, Gaddipati R, Elnabawi YA, Ongstad E, Goyal A, Chung JH, Teague HL, Rodante JA, Sajja AA, Sorokin AV, Lateef SS, Aksentijevich M, Choi H, Reddy AS, Varghese NJ, Groenendyk J, Belur AD, Genovese L, Rivers JP, Lerman J, Kabbany MT, Harrington C, Ortiz J, Khalil N, Keel A, Baumer Y, Chen MY, Bluemke DA, Joshi AA, Kaplan MJ, Remaley AT, Playford MP, Karathanasis SK, Gelfand JM, Gupta R, Mehta NN.

JAMA Dermatol. 2019 Nov 20. doi: 10.1001/jamadermatol.2019.3595. [Epub ahead of print]

PMID:
31746956
2.

Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial.

Demidowich AP, Wolska A, Wilson SR, Levine JA, Sorokin AV, Brady SM, Remaley AT, Yanovski JA.

J Clin Lipidol. 2019 Oct 22. pii: S1933-2874(19)30318-6. doi: 10.1016/j.jacl.2019.10.011. [Epub ahead of print]

PMID:
31740368
3.

Familial Chylomicronemia Syndrome With a Novel Homozygous LPL Mutation Identified in Three Siblings in Their 50s.

Ueda M, Burke FM, Remaley AT, Hegele RA, Rader DJ, Dunbar RL.

Ann Intern Med. 2019 Nov 19. doi: 10.7326/L19-0568. [Epub ahead of print] No abstract available.

PMID:
31739313
4.

Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL.

El-Khoury JM, Remaley AT, Nordestgaard BG, Kaufman HW, Mora S, Cao J, Meeusen JW.

Clin Chem. 2019 Nov 7. pii: clinchem.2019.307306. doi: 10.1373/clinchem.2019.307306. [Epub ahead of print] No abstract available.

PMID:
31699699
5.

Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis.

Lucero D, Islam P, Freeman LA, Jin X, Pryor M, Tang J, Kruth HS, Remaley AT.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct 30;1865(2):158537. doi: 10.1016/j.bbalip.2019.158537. [Epub ahead of print]

PMID:
31676439
6.

The Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.

Chung ST, Cravalho CK, Meyers AG, Courville AB, Yang S, Matthan NR, Mabundo L, Sampson M, Ouwerkerk R, Gharib AM, Lichtenstein AH, Remaley AT, Sumner AE.

Circ Res. 2019 Oct 18. doi: 10.1161/CIRCRESAHA.119.315701. [Epub ahead of print]

PMID:
31623522
7.

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.

Hegele RA, Borén J, Ginsberg HN, Arca M, Averna M, Binder CJ, Calabresi L, Chapman MJ, Cuchel M, von Eckardstein A, Frikke-Schmidt R, Gaudet D, Hovingh GK, Kronenberg F, Lütjohann D, Parhofer KG, Raal FJ, Ray KK, Remaley AT, Stock JK, Stroes ES, Tokgözoğlu L, Catapano AL.

Lancet Diabetes Endocrinol. 2019 Sep 30. pii: S2213-8587(19)30264-5. doi: 10.1016/S2213-8587(19)30264-5. [Epub ahead of print] Review.

PMID:
31582260
8.

Commentary.

Wolska A, Remaley AT.

Clin Chem. 2019 Oct;65(10):1219-1220. doi: 10.1373/clinchem.2019.304550. No abstract available.

PMID:
31570413
9.

Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach.

Reimund M, Wolska A, Risti R, Wilson S, Sviridov D, Remaley AT, Lookene A.

Biochem Biophys Res Commun. 2019 Oct 29;519(1):67-72. doi: 10.1016/j.bbrc.2019.08.130. Epub 2019 Aug 30.

PMID:
31477272
10.

ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid.

Neufeld EB, Sato M, Gordon SM, Durbhakula V, Francone N, Aponte A, Yilmaz G, Sviridov D, Sampson M, Tang J, Pryor M, Remaley AT.

Biology (Basel). 2019 Jul 12;8(3). pii: E53. doi: 10.3390/biology8030053.

11.

LDL Cholesterol: What Is the Best Way to Measure It?

Wolska A, Remaley AT.

Clin Chem. 2019 Sep;65(9):1067-1069. doi: 10.1373/clinchem.2019.307678. Epub 2019 Jul 15. No abstract available.

PMID:
31307995
12.

microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke.

Tabet F, Lee S, Zhu W, Levin MG, Toth CL, Cuesta Torres LF, Vinh A, Kim HA, Chu HX, Evans MA, Kuzmich ME, Drummond GR, Remaley AT, Rye KA, Sobey CG, Vickers KC.

J Cereb Blood Flow Metab. 2019 Jul 11:271678X19858637. doi: 10.1177/0271678X19858637. [Epub ahead of print]

PMID:
31296130
13.

Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction.

Sposito AC, de Lima-Junior JC, Moura FA, Barreto J, Bonilha I, Santana M, Virginio VW, Sun L, Carvalho LSF, Soares AAS, Nadruz W, Feinstein SB, Nofer JR, Zanotti I, Kontush A, Remaley AT.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1550-1564. doi: 10.1161/ATVBAHA.119.312880. Epub 2019 Jun 13.

PMID:
31189429
14.

HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation.

Zhang Y, Gordon SM, Xi H, Choi S, Paz MA, Sun R, Yang W, Saredy J, Khan M, Remaley AT, Wang JF, Yang X, Wang H.

Redox Biol. 2019 Jun;24:101222. doi: 10.1016/j.redox.2019.101222. Epub 2019 May 17.

15.

Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks.

Makri A, Cheung A, Sinaii N, Remaley AT, Sampson M, Keil M, Belyavskaya E, Lyssikatos C, De La Luz Sierra M, Stratakis CA, Lodish M.

Pediatr Res. 2019 Sep;86(3):375-381. doi: 10.1038/s41390-019-0438-0. Epub 2019 May 21.

PMID:
31112990
16.

Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial.

Ferguson JJA, Wolska A, Remaley AT, Stojanovski E, MacDonald-Wicks L, Garg ML.

Food Funct. 2019 May 22;10(5):2515-2527. doi: 10.1039/c8fo02512f.

PMID:
30990213
17.

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.

Gourgari E, Ma J, Playford MP, Mehta NN, Goldman R, Remaley AT, Gordon SM.

Cardiovasc Diabetol. 2019 Mar 28;18(1):43. doi: 10.1186/s12933-019-0846-9.

18.

Dietary Palmitoleic Acid Attenuates Atherosclerosis Progression and Hyperlipidemia in Low-Density Lipoprotein Receptor-Deficient Mice.

Yang ZH, Pryor M, Noguchi A, Sampson M, Johnson B, Pryor M, Donkor K, Amar M, Remaley AT.

Mol Nutr Food Res. 2019 Jun;63(12):e1900120. doi: 10.1002/mnfr.201900120. Epub 2019 Apr 10.

PMID:
30921498
19.

Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice.

Komatsu T, Sakurai T, Wolska A, Amar MJ, Sakurai A, Vaisman BL, Sviridov D, Demosky S, Pryor M, Ikewaki K, Remaley AT.

J Nutr Metab. 2019 Feb 3;2019:7078241. doi: 10.1155/2019/7078241. eCollection 2019.

20.

DENND5B Regulates Intestinal Triglyceride Absorption and Body Mass.

Gordon SM, Neufeld EB, Yang Z, Pryor M, Freeman LA, Fan X, Kullo IJ, Biesecker LG, Remaley AT.

Sci Rep. 2019 Mar 5;9(1):3597. doi: 10.1038/s41598-019-40296-0.

21.

Where There Is Smoke, There Is Fire.

Wolska A, Levine SJ, Remaley AT.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):306-308. doi: 10.1161/ATVBAHA.119.312398. No abstract available.

PMID:
30811249
22.

Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Freeman LA, Shamburek RD, Sampson ML, Neufeld EB, Sato M, Karathanasis SK, Remaley AT.

J Lipid Res. 2019 May;60(5):1050-1057. doi: 10.1194/jlr.D090233. Epub 2019 Feb 26.

PMID:
30808683
23.

High-density lipoprotein lifts the "dark web" cast by neutrophils.

Lucero D, Neufeld EB, Remaley AT.

Ann Transl Med. 2018 Nov;6(Suppl 1):S24. doi: 10.21037/atm.2018.09.28. No abstract available.

24.

Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, Ueda M, Harrington CL, Baumer Y, Rodante JA, Gelfand JM, Chen MY, Joshi AA, Playford MP, Remaley AT, Mehta NN.

Circ Res. 2018 Nov 9;123(11):1244-1254. doi: 10.1161/CIRCRESAHA.118.313608.

25.

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study.

Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN.

Cardiovasc Diabetol. 2018 Dec 19;17(1):158. doi: 10.1186/s12933-018-0802-0.

26.

LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Vaisman BL, Neufeld EB, Freeman LA, Gordon SM, Sampson ML, Pryor M, Hillman E, Axley MJ, Karathanasis SK, Remaley AT.

J Pharmacol Exp Ther. 2019 Mar;368(3):423-434. doi: 10.1124/jpet.118.251876. Epub 2018 Dec 18.

27.

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Manthei KA, Yang SM, Baljinnyam B, Chang L, Glukhova A, Yuan W, Freeman LA, Maloney DJ, Schwendeman A, Remaley AT, Jadhav A, Tesmer JJ.

Elife. 2018 Nov 27;7. pii: e41604. doi: 10.7554/eLife.41604.

28.

Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.

Tsujita M, Wolska A, Gutmann DAP, Remaley AT.

Curr Atheroscler Rep. 2018 Nov 5;20(12):59. doi: 10.1007/s11883-018-0759-1. Review.

PMID:
30397748
29.

Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys.

Bourdi M, Amar M, Remaley AT, Terse PS.

Regul Toxicol Pharmacol. 2018 Dec;100:59-67. doi: 10.1016/j.yrtph.2018.10.009. Epub 2018 Oct 22.

PMID:
30359697
30.

Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?

Vitali C, Remaley AT, Cuchel M.

Circulation. 2018 Sep 4;138(10):1008-1011. doi: 10.1161/CIRCULATIONAHA.118.035358. No abstract available.

PMID:
30354544
31.

High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

Gordon SM, Chung JH, Playford MP, Dey AK, Sviridov D, Seifuddin F, Chen YC, Pirooznia M, Chen MY, Mehta NN, Remaley AT.

Atherosclerosis. 2018 Nov;278:278-285. doi: 10.1016/j.atherosclerosis.2018.09.032. Epub 2018 Sep 25.

32.

Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity.

Wu MJ, Wolska A, Roberts BS, Pearson EM, Gutgsell AR, Remaley AT, Neher SB.

J Lipid Res. 2018 Dec;59(12):2456-2465. doi: 10.1194/jlr.D086793. Epub 2018 Oct 14.

PMID:
30318473
33.

GlycA is not a useful biomarker of inflammation in sickle cell disease.

Weisman JK, Meeks D, Mendelsohn L, Remaley AT, Sampson M, Allen DT, Nichols J, Shet AS, Thein SL.

Int J Lab Hematol. 2018 Dec;40(6):704-709. doi: 10.1111/ijlh.12907. Epub 2018 Aug 27.

34.

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis.

Liu Y, Carmona-Rivera C, Moore E, Seto NL, Knight JS, Pryor M, Yang ZH, Hemmers S, Remaley AT, Mowen KA, Kaplan MJ.

Front Immunol. 2018 Jul 26;9:1680. doi: 10.3389/fimmu.2018.01680. eCollection 2018.

35.

Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot.

Sapp JC, Johnston JJ, Driscoll K, Heidlebaugh AR, Miren Sagardia A, Dogbe DN, Umstead KL, Turbitt E, Alevizos I, Baron J, Bönnemann C, Brooks B, Donkervoort S, Jee YH, Linehan WM, McMahon FJ, Moss J, Mullikin JC, Nielsen D, Pelayo E, Remaley AT, Siegel R, Su H, Zarate C; NISC Comparative Sequencing Program, Manolio TA, Biesecker BB, Biesecker LG.

Am J Hum Genet. 2018 Sep 6;103(3):358-366. doi: 10.1016/j.ajhg.2018.07.018. Epub 2018 Aug 16.

36.

Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization.

Delatour V, Clouet-Foraison N, Gaie-Levrel F, Marcovina SM, Hoofnagle AN, Kuklenyik Z, Caulfield MP, Otvos JD, Krauss RM, Kulkarni KR, Contois JH, Remaley AT, Vesper HW, Cobbaert CM, Gillery P.

Clin Chem. 2018 Oct;64(10):1485-1495. doi: 10.1373/clinchem.2018.288746. Epub 2018 Aug 7.

37.

Correlative Detection of Isolated Single and Multi-Cellular Calcifications in the Internal Elastic Lamina of Human Coronary Artery Samples.

Wen H, Morales Martinez A, Miao H, Larsen TC, Nguyen CP, Bennett EE, Moorse KP, Yu ZX, Remaley AT, Boehm M, Gharib AM.

Sci Rep. 2018 Jul 20;8(1):10978. doi: 10.1038/s41598-018-29379-6.

38.

Cardiovascular Benefits of Phenol-Enriched Virgin Olive Oils: New Insights from the Virgin Olive Oil and HDL Functionality (VOHF) Study.

Pedret A, Fernández-Castillejo S, Valls RM, Catalán Ú, Rubió L, Romeu M, Macià A, López de Las Hazas MC, Farràs M, Giralt M, Mosele JI, Martín-Peláez S, Remaley AT, Covas MI, Fitó M, Motilva MJ, Solà R.

Mol Nutr Food Res. 2018 Aug;62(16):e1800456. doi: 10.1002/mnfr.201800456. Epub 2018 Jul 30.

PMID:
29956886
39.

A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Cooke AL, Morris J, Melchior JT, Street SE, Jerome WG, Huang R, Herr AB, Smith LE, Segrest JP, Remaley AT, Shah AS, Thompson TB, Davidson WS.

J Lipid Res. 2018 Jul;59(7):1244-1255. doi: 10.1194/jlr.M085332. Epub 2018 May 17.

40.

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, Watts GF, Borén J, Baum H, Bruckert E, Catapano A, Descamps OS, von Eckardstein A, Kamstrup PR, Kolovou G, Kronenberg F, Langsted A, Pulkki K, Rifai N, Sypniewska G, Wiklund O, Nordestgaard BG; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem. 2018 Jul;64(7):1006-1033. doi: 10.1373/clinchem.2018.287037. Epub 2018 May 14.

41.

Resolution of Lipoprotein Subclasses by Charge Detection Mass Spectrometry.

Lutomski CA, Gordon SM, Remaley AT, Jarrold MF.

Anal Chem. 2018 Jun 5;90(11):6353-6356. doi: 10.1021/acs.analchem.8b01127. Epub 2018 May 14.

PMID:
29756771
42.

Lipoprotein lipase regulates hematopoietic stem progenitor cell maintenance through DHA supply.

Liu C, Han T, Stachura DL, Wang H, Vaisman BL, Kim J, Klemke RL, Remaley AT, Rana TM, Traver D, Miller YI.

Nat Commun. 2018 Apr 3;9(1):1310. doi: 10.1038/s41467-018-03775-y.

43.

Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.

Islam RM, Pourmousa M, Sviridov D, Gordon SM, Neufeld EB, Freeman LA, Perrin BS Jr, Pastor RW, Remaley AT.

Sci Rep. 2018 Feb 13;8(1):2956. doi: 10.1038/s41598-018-20965-2.

44.

Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.

Sasamura A, Akazawa S, Haraguchi A, Horie I, Ando T, Abiru N, Takei H, Nittono H, Une M, Kurosawa T, Murai T, Naruse H, Nakayama T, Kotani K, Remaley AT, Kawakami A.

Intern Med. 2018 Jun 1;57(11):1611-1616. doi: 10.2169/internalmedicine.0120-17. Epub 2018 Feb 9.

45.

A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis.

Cao J, Steffen BT, Guan W, Remaley AT, McConnell JP, Palamalai V, Tsai MY.

J Clin Lipidol. 2018 Mar - Apr;12(2):300-304. doi: 10.1016/j.jacl.2017.12.013. Epub 2017 Dec 29.

PMID:
29370999
46.

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.

Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L.

J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014. Review.

47.

Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients.

Jorissen W, Vanmierlo T, Wens I, Somers V, Van Wijmeersch B, Bogie JF, Remaley AT, Eijnde BO, Hendriks JJA.

Int J Mol Sci. 2018 Jan 8;19(1). pii: E193. doi: 10.3390/ijms19010193.

48.

Effects of Multiple Freeze/Thaw Cycles on Measurements of Potential Novel Biomarkers Associated With Adverse Pregnancy Outcomes.

Rebholz SL, Melchior JT, Welge JA, Remaley AT, Davidson WS, Woollett LA.

J Clin Lab Med. 2017;2(1). doi: 10.16966/2572-9578.107. Epub 2017 Feb 21.

49.

Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy.

Guber RD, Takyar V, Kokkinis A, Fox DA, Alao H, Kats I, Bakar D, Remaley AT, Hewitt SM, Kleiner DE, Liu CY, Hadigan C, Fischbeck KH, Rotman Y, Grunseich C.

Neurology. 2017 Dec 12;89(24):2481-2490. doi: 10.1212/WNL.0000000000004748. Epub 2017 Nov 15.

50.

Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.

Li D, Fawaz MV, Morin EE, Ming R, Sviridov D, Tang J, Ackermann R, Olsen K, Remaley AT, Schwendeman A.

Mol Pharm. 2018 Jan 2;15(1):83-96. doi: 10.1021/acs.molpharmaceut.7b00734. Epub 2017 Nov 29.

Supplemental Content

Loading ...
Support Center